Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis

August 15, 2024
REGENERON PHARMACEUTICALS, INC. has achieved the price target forecast set by QuantWave, resulting in a profit of 19.37%. The forecast signal was given on May 14, 2024, indicating a long position with the stock trading at 981.93 $. On August 15, 2024, the target price of 1172.09 $ was reached, validating the accuracy of the prediction.

This successful forecast can be attributed to several factors influencing the stock's movement, including positive developments in the pharmaceutical industry, company-specific news, and market trends. QuantWave's advanced analytics and algorithmic models played a crucial role in identifying these factors and generating an accurate forecast for REGENERON PHARMACEUTICALS, INC.

QuantWave is a cutting-edge automated forecasting platform that provides predictions for a wide range of stocks, offering users the potential for profitable opportunities in the market. For investors seeking a deeper understanding of QuantWave's investment strategy, QuantSchool offers comprehensive educational resources. QuantSchool teaches the fundamental principles for generating consistent income using the QuantWave forecasting system, empowering users to make informed investment decisions.

Find out how the REGENERON PHARMACEUTICALS, INC. rate is expected to change

Get Forecast for REGN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for REGN

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits 29.73% Profit Target as Forecasted by QuantWave  ~1 min.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) achieved a significant milestone as it hit the price target forecasted by QuantWave, providing investors with a profit of 29.73%....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Short Forecast Target with 17.43% Profit  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on July 1, 2022, predicted a short direction with a price of $593.76....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 21.51% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profitable outcome for investors....



Related news

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30.6% for investors who followed the short signal....

REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 18.25% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Short Forecast Target with 20.49% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) recently saw its stock hit a price target forecasted by QuantWave, with a profit of 20.49% for investors who followed the short signal....